GSK2245035 [1207629-49-9]

TargetMol Chemicals

GSK2245035 [1207629-49-9]

86

1207629-49-9

Research Use Only

GSK2245035

C20H34N6O2

390.52

GSK2245035 is a highly selective intranasal TLR7 agonist with preferential Type-1 interferon (IFN)-stimulating properties (pEC50s: 9.3 and 6.5 for IFNalpha and TFNalpha). It effectively suppresses allergen-induced Th2 cytokine production in human peripheral blood cell cultures.

3 years

CCC[C@H](C)Oc1nc(N)c2[nH]c(=O)n(CCCCCN3CCCCC3)c2n1

-20°C

12352200